Table 3.
Tissue AKR1B10 expression and serum AFP levels with HCC at the different BCLC stages.
| BCLC stage | Number | IOD of AKR1B10 | AFP (ng/ml) |
|---|---|---|---|
| Early stage | 29 | 219.1±232.8* | 605.6±2316.1 |
| Intermediate stage | 7 | 124.5±138.5 | 4028.7±5903.4 |
| Advanced stage | 8 | 12.6±17.8 | 4097.1±7302.7# |
| P-value | 0.038@ | 0.046@ |
Data are described as mean ± standard deviation.
@
One-way analysis of variance (ANOVA);
*
P-values are for comparisons between HCC patients with and without early stage;
#
P-values are for comparisons between HCC patients with and without advanced stage.
AKR1B10 – aldo-keto reductase family 1 member B10; AFP – alpha-fetoprotein; HCC – hepatocellular carcinoma; BCLC – Barcelona Clinic Liver Cancer; IOD – integral optical density.